Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

Drug-tolerant but initially EGFRT790M-negative tumor cells that undergo genetic evolution to acquire resistance to EGFR inhibitors are more resistant than pre-existing EGFRT790M -positive clones to subsequent therapy.